Your browser doesn't support javascript.
loading
Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success.
Kim, Beom Jin; Yang, Chang-Hun; Song, Hyun Joo; Jeon, Seong Woo; Kim, Gwang Ha; Kim, Hyun-Soo; Kim, Tae Ho; Shim, Ki-Nam; Chung, Il-Kwun; Park, Moo In; Choi, Il Ju; Kim, Ji Hyun; Kim, Byung-Wook; Baik, Gwang Ho; Han, Sok Won; Seo, Hyang Eun; Jung, Woon Tae; Hwan Oh, Jung; Kim, Sang Gyun; Lee, Jun Haeng; Park, Sue K; Park, Byung-Joo; Yang, Bo Ram; Lee, Joongyub; Kim, Jae G.
Afiliación
  • Kim BJ; Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Yang CH; Department of Internal Medicine, Dongguk University College of Medicine Gyeongju Hospital, Gyeongju, Korea.
  • Song HJ; Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
  • Jeon SW; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Korea.
  • Kim GH; Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
  • Kim HS; Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.
  • Kim TH; Department of Gastroenterology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
  • Shim KN; Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.
  • Chung IK; Department of Internal Medicine, Cheonan Hospital, Soon Chun Hyang University College of Medicine, Cheonan, Korea.
  • Park MI; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Korea.
  • Choi IJ; Center for Gastric Cancer, National Cancer Center, Gyeonggi, Korea.
  • Kim JH; Department of Internal Medicine, Pusan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Kim BW; Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Incheon, Korea.
  • Baik GH; Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.
  • Han SW; Department of Gastroenterology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
  • Seo HE; Department of Internal Medicine, Daegu Fatima Hospital, Daegu, Korea.
  • Jung WT; Department of Internal Medicine, Gyeongsang National University School of Medicine, Jinju, Korea.
  • Hwan Oh J; Department of Internal Medicine, St. Paul's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Kim SG; Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Lee JH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Park SK; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Park BJ; Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea.
  • Yang BR; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Lee J; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Kim JG; Department of Biomedical Science, Seoul National University Graduate School, Seoul, Korea.
Helicobacter ; 24(5): e12646, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31368629
BACKGROUND: The Helicobacter pylori eradication rate has decreased with increasing antibiotic resistance. We conducted a prospective, nationwide, multicenter registry study to monitor the real status of H. pylori eradication therapy and to investigate the association between eradication success and antibiotic use density in Korea. MATERIALS AND METHODS: We enrolled 9318 patients undergoing H. pylori eradication therapy from 37 hospitals through "on-line database registry" from October 2010 to July 2015. Demographic data, detection methods, treatment indications, regimens, durations, compliance, adverse events, and eradication results were collected. The use of all commercially available eradication antibiotics was analyzed through the Korean National Health Insurance data of the Health Insurance Review and Assessment Service. The defined daily dose of antibiotics was used to standardize drug use comparisons. RESULTS: Finally, 6738 patients were analyzed. The overall eradication rate of first-line therapy was 71.8%. The eradication success rates were 71.7%, 86.9%, and 74.0% for standard triple therapy for 7 days, quadruple therapy, and concomitant therapy, respectively. The eradication success rate in naive patients was higher than that in those who previously underwent H. pylori eradication. Eradication success was significantly associated with younger age, female sex, and high compliance. Regional differences in eradication rates were observed. The yearly use density of clarithromycin increased statistically in seven regions across the country from 2010 to 2015. The yearly use density of amoxicillin in the Gyeongsang and Chungcheong areas was significantly increased (P < .01), whereas that of other macrolides was significantly lower in the Gyeonggi area than in other areas (P = .01). The overall use of eradication antibiotics has increased while the eradication rate steadily decreased for 5 years. However, there was no significant correlation between antibiotic use density and eradication. CONCLUSION: There was no relationship between the eradication rate and antibiotic use density in Korea.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Bases de Datos Factuales / Infecciones por Helicobacter / Internet / Utilización de Medicamentos / Antibacterianos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Helicobacter Asunto de la revista: BACTERIOLOGIA Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sistema de Registros / Bases de Datos Factuales / Infecciones por Helicobacter / Internet / Utilización de Medicamentos / Antibacterianos Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Helicobacter Asunto de la revista: BACTERIOLOGIA Año: 2019 Tipo del documento: Article